Ratings by H.C. Wainwright (Mitchell Kapoor)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/25/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 6/22/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/16/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2026 | Damora Therapeutics | DMRA | New Coverage | Buy (N/A) |
20.15 (22.57) |
12.01% | Details | |
| 6/10/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 6/1/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 5/26/2026 | Evommune Inc | EVMN | Maintain | Buy (Buy) |
|
Details | ||
| 5/22/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/21/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2026 | Generate Biomedicines | GENB | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2026 | Evommune Inc | EVMN | Maintain | Buy (Buy) |
|
Details | ||
| 4/15/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2026 | Generate Biomedicines | GENB | New Coverage | Buy (N/A) |
11.41 (16.42) |
43.91% | Details | |
| 3/31/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2026 | Evommune Inc | EVMN | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2026 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/17/2026 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Evommune Inc | EVMN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2026 | Incyte | INCY | New Coverage | Buy (N/A) |
102.60 (107.53) |
4.81% | Details | |
| 1/29/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2026 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Instil Bio Inc | TIL | Downgrade | Neutral (Buy) |
6.66 (7.46) |
12.01% | Details | |
| 1/6/2026 | Evommune Inc | EVMN | New Coverage | Buy (N/A) |
15.37 (24.13) |
56.99% | Details | |
| 12/22/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/28/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 10/31/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2025 | Instil Bio Inc | TIL | Maintain | Buy (Buy) |
|
Details | ||
| 9/8/2025 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Neutral (N/A) |
57.77 (57.35) |
-0.73% | Details | |
| 9/3/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2025 | Verve Therapeutics | VERV | Downgrade | Neutral (Buy) |
11.38 (11.13) |
-2.2% | Details | |
| 6/5/2025 | Instil Bio Inc | TIL | Maintain | Buy (Buy) |
|
Details | ||
| 5/29/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 5/23/2025 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2025 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 4/24/2025 | Century Therapeutics | IPSC | Maintain | Buy (Buy) |
|
Details | ||
| 4/9/2025 | Rallybio Corp. | RLYB | Downgrade | Neutral (Buy) |
0.25 (15.71) |
6184% | Details | |
| 4/8/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2025 | Ionis Pharmaceuticals | IONS | New Coverage | Buy (N/A) |
27.09 (78.34) |
189.18% | Details | |
| 4/3/2025 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2025 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Lexeo Therapeutics | LXEO | Maintain | Buy (Buy) |
|
Details | ||
| 3/6/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Verve Therapeutics | VERV | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2025 | CRISPR Therapeutics | CRSP | New Coverage | Buy (N/A) |
41.59 (53.98) |
29.79% | Details | |
| 12/30/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 12/18/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 12/16/2024 | Carisma Therapeutics Inc | CARM | Downgrade | Neutral (Buy) |
0.40 (0.15) |
-62.5% | Details | |
| 12/3/2024 | Rallybio Corp. | RLYB | Maintain | Buy (Buy) |
|
Details | ||
| 11/25/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 11/25/2024 | Carisma Therapeutics Inc | CARM | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Verve Therapeutics | VERV | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 10/7/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Rallybio Corp. | RLYB | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2024 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Rallybio Corp. | RLYB | Maintain | Buy (Buy) |
|
Details | ||
| 8/23/2024 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Lexeo Therapeutics | LXEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2024 | Lexeo Therapeutics | LXEO | Maintain | Buy (Buy) |
|
Details | ||
| 7/16/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 7/3/2024 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2024 | Carisma Therapeutics Inc | CARM | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 6/7/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2024 | Lexeo Therapeutics | LXEO | New Coverage | Buy (N/A) |
17.19 (4.70) |
-72.66% | Details | |
| 5/10/2024 | Carisma Therapeutics Inc | CARM | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Verve Therapeutics | VERV | New Coverage | Buy (N/A) |
8.52 (11.13) |
30.63% | Details | |
| 4/2/2024 | Carisma Therapeutics Inc | CARM | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2024 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Neutral (Buy) |
1.34 (1.82) |
35.82% | Details | |
| 11/10/2023 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2023 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2023 | Reneo Pharmaceuticals | RPHM | New Coverage | Buy (N/A) |
6.25 (1.82) |
-70.88% | Details | |
| 8/11/2023 | Carisma Therapeutics Inc | CARM | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
42.89 (72.64) |
69.36% | Details | |
| 6/29/2023 | Instil Bio Inc | TIL | New Coverage | Buy (N/A) |
0.54 (6.66) |
1133.33% | Details | |
| 5/24/2023 | Carisma Therapeutics Inc | CARM | New Coverage | Buy (N/A) |
5.24 (0.15) |
-97.14% | Details | |
| 5/23/2023 | Rain Therapeutics | RAIN | Downgrade | Neutral (Buy) |
1.22 (2.00) |
63.93% | Details | |
| 4/17/2023 | Rallybio Corp. | RLYB | New Coverage | Buy (N/A) |
4.31 (15.71) |
264.5% | Details | |
| 3/17/2023 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Imago Biosciences Inc | IMGO | Downgrade | Neutral (Buy) |
35.59 (36.01) |
1.18% | Details | |
| 11/14/2022 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Rain Therapeutics | RAIN | New Coverage | Buy (N/A) |
5.70 (2.00) |
-64.91% | Details | |
| 6/23/2022 | Tyra Biosciences | TYRA | New Coverage | Buy (N/A) |
6.27 (30.94) |
393.46% | Details | |
| 5/23/2022 | Century Therapeutics | IPSC | New Coverage | Buy (N/A) |
8.51 (2.30) |
-72.97% | Details | |
| 2/14/2022 | Imago Biosciences Inc | IMGO | New Coverage | Buy (N/A) |
23.95 (36.01) |
50.35% | Details |
